Description
This diabetes education course provides an in-depth look at the ongoing obesity epidemic and highlights the latest advancements in treatment. Attendees will explore new FDA-approved Semaglutide and Tirzepatide medications, gaining insights into their efficacy, mechanisms, and clinical applications. This session aims to equip participants with up-to-date knowledge to better manage and understand obesity and diabetes.